Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06695767 · ClinicalTrials.gov registry record · NA

Neurobehavioral Therapy For Epilepsy And Major Depressive Disorder

A NA study of Major Depressive Disorder and Epilepsy, sponsored by The University of Texas Health Science Center, Houston.

Recruiting
Registry status
NA
Development phase
16
Enrollment target
2
Study locations

NCT06695767 is a NA study of Major Depressive Disorder and Epilepsy that is actively recruiting participants, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 16 participants, below the 377-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (96% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06695767, a NA study of Major Depressive Disorder and Epilepsy, is actively recruiting participants, sponsored by The University of Texas Health Science Center, Houston.

RECRUITING
Registry status
NA
Development phase
16 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this study is to examine the feasibility and acceptability of an online group Neuro-behavioral Therapy (NBT) with text messaging intervention for Veterans with epilepsy and major depressive disorder (MDD).

Interventions

  • BEHAVIORAL Neurobehavioral therapy

Study Locations (2)

Texas

  • Michael E. DeBakey VA Medical Center - Houston
  • The University of Texas health Science Center at Houston - Houston

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2024-12-19
Est. Completion 2025-04-01
Phase NA

What the Registry Record Tells You About NCT06695767

The ClinicalTrials.gov registry entry for NCT06695767 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 377-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (96% lower). The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Major Depressive Disorder appearing as the primary indexed condition, and to 1 intervention - of which Neurobehavioral therapy is the first listed.

NCT06695767 reports 2 study locations spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT06695767 about?

NCT06695767 is a clinical study titled "Neurobehavioral Therapy For Epilepsy And Major Depressive Disorder". The purpose of this study is to examine the feasibility and acceptability of an online group Neuro-behavioral Therapy (NBT) with text messaging intervention for Veterans with epilepsy and major depressive disorder (MDD).

What is the current status of trial NCT06695767?

This trial is currently recruiting. It is a NA study. The enrollment target is 16 participants. The study started on 2024-12-19. Estimated completion is 2025-04-01.

What conditions does trial NCT06695767 study?

This clinical trial studies the following conditions: Major Depressive Disorder, Epilepsy.

What interventions are being tested in trial NCT06695767?

The interventions under investigation include: Neurobehavioral therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT06695767?

This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06695767 being conducted?

This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Major Depressive Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.